GGrantIndex
← Leaderboards

Dongming Cai

Minneapolis Va Medical Center

$14,702,989
Attributed
$27,113,037
Total exposure
15
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.5M · FY201525
$10M$7.5M$5M$2.5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$27,113,037 · 10
VA$0 · 5

By mechanism

R01$13,893,681 · 4
RF1$9,977,874 · 3
UH3$1,223,120 · 1
UH2$1,177,592 · 1
R56$840,770 · 1
I01$0 · 3

Top collaborators

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposS DiseaseBrainMouse ModelPathway InteractionsPathogenesisApolipoprotein E-4Cognitive DeficitsIn VivoMolecularDementiaPathogenicityChronicSamplingCellsLeadMolecular ProfilingStructureApolipoprotein ENovel TherapeuticsPhospholipidsNeurodegenerative DisordersKnock-In MouseRegulation

Grant awards (46)

Research Infrastructure for the study of Alzheimer's Disease and Alzheimer's Disease-related dementias in older Asian Americans$1,223,120
UH3 · FY2025 · AG
Dissect the interplay between sex and APOE at the single cell level to uncover novel pathways, targets and therapeutics for Alzheimer's disease$1,189,149
R01 · FY2025 · AG
Transcriptional Control of Neuroinflammation in Alzheimer's Disease$827,161
R01 · FY2025 · AG
Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis$648,233
R01 · FY2025 · AG · contact PI
MicroRNA Regulation of Phospholipid Homeostasis in Alzheimer's Disease Pathogenesis$0
I01 · FY2025 · VA · contact PI
Novel Disease-modifying Small Molecules for Treatment of Alzheimer's Disease”$0
I01 · FY2025 · VA · contact PI
Dissect the interplay between sex and APOE at the single cell level to uncover novel pathways, targets and therapeutics for Alzheimer's disease$1,217,104
R01 · FY2024 · AG
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease$844,721
R01 · FY2024 · AG
Transcriptional Control of Neuroinflammation in Alzheimer's Disease$844,584
R01 · FY2024 · AG
Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis$711,403
R01 · FY2024 · AG · contact PI
Research Infrastructure for the study of Alzheimer's Disease and Alzheimer's Disease-related dementias in older Asian Americans$588,100
UH2 · FY2024 · AG
MicroRNA Regulation of Phospholipid Homeostasis in Alzheimer's Disease Pathogenesis$0
I01 · FY2024 · VA · contact PI
Novel Disease-modifying Small Molecules for Treatment of Alzheimer's Disease”$0
I01 · FY2024 · VA · contact PI
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease$846,972
R01 · FY2023 · AG
Transcriptional Control of Neuroinflammation in Alzheimer's Disease$842,864
R01 · FY2023 · AG
Research Infrastructure for the study of Alzheimer's Disease and Alzheimer's Disease-related dementias in older Asian Americans$589,492
UH2 · FY2023 · AG
Novel Disease-modifying Small Molecules for Treatment of Alzheimer's Disease”$0
I01 · FY2023 · VA · contact PI
MicroRNA Regulation of Phospholipid Homeostasis in Alzheimer's Disease Pathogenesis$0
I01 · FY2023 · VA · contact PI
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease$847,014
R01 · FY2022 · AG
Transcriptional Control of Neuroinflammation in Alzheimer's Disease$836,885
R01 · FY2022 · AG
Novel small molecules targeting brain phospholipid dysregulation in AD$0
I01 · FY2022 · VA · contact PI
MicroRNA Regulation of Phospholipid Homeostasis in Alzheimer's Disease Pathogenesis$0
I01 · FY2022 · VA · contact PI
Dissect the interplay between sex and APOE at the single cell level to uncover novel pathways, targets and therapeutics for Alzheimer's disease$3,641,905
RF1 · FY2021 · AG
Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis$1,431,396
RF1 · FY2021 · AG · contact PI
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease$847,487
R01 · FY2021 · AG
Transcriptional Control of Neuroinflammation in Alzheimer's Disease$844,476
R01 · FY2021 · AG
Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis$693,456
RF1 · FY2021 · AG · contact PI
Novel small molecules targeting brain phospholipid dysregulation in AD$0
I01 · FY2021 · VA · contact PI
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease$845,873
R01 · FY2020 · AG
MicroRNA Regulation of Phospholipid Homeostasis in Alzheimer's Disease Pathogenesis$0
I01 · FY2020 · VA · contact PI
Novel small molecules targeting brain phospholipid dysregulation in AD$0
I01 · FY2020 · VA · contact PI
Characterization of protective roles of ApoE2 against aging and Alzheimer's disease$840,770
R56 · FY2019 · AG · contact PI
Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis$339,951
R01 · FY2019 · AG · contact PI
MicroRNA Regulation of Phospholipid Homeostasis in Alzheimer's Disease Pathogenesis$0
I01 · FY2019 · VA · contact PI
Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis$339,951
R01 · FY2018 · AG · contact PI
Novel small molecules targeting brain phospholipid dysregulation in AD$0
I01 · FY2018 · VA · contact PI
ShEEP Request for an Agilent 9470 Triple Quadrupole LC/MS Detection System with Jet Stream Technology$0
IS1 · FY2018 · VA · contact PI
MicroRNA Regulation of Phospholipid Homeostasis in Alzheimer's Disease Pathogenesis$0
I01 · FY2018 · VA · contact PI
Novel small molecules targeting brain phospholipid dysregulation in AD$0
I01 · FY2018 · VA · contact PI
Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis$339,951
R01 · FY2017 · AG · contact PI
MicroRNA Regulation of Phospholipid Homeostasis in Alzheimer's Disease Pathogenesis$0
I01 · FY2017 · VA · contact PI
Molecular Characterization and Validation of Gender Differences in Alzheimers Disease Pathogenesis$4,211,117
RF1 · FY2016 · AG
Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis$339,951
R01 · FY2016 · AG · contact PI
Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis$339,951
R01 · FY2015 · AG · contact PI
Development of Novel Therapies for AD Targeting Abeta Clearance$0
I21 · FY2015 · VA · contact PI
Development of Novel Therapies for AD Targeting Abeta Clearance$0
I21 · FY2015 · VA · contact PI